COVID-19与非COVID-19危重症幸存者6个月结局比较
该研究比较了澳大利亚ICU中接受机械通气的COVID-19与非COVID-19危重症患者6个月时的新发残疾情况。结果显示,尽管COVID-19患者通气时间更长,但180天死亡率及死亡或新发残疾发生率两组间无差异。
要点
- COVID-19组机械通气时间显著长于非COVID-19组。
- 两组180天死亡率相似,无统计学差异。
- 两组180天死亡或新发残疾发生率无显著差异。
核心结论
- 对于因急性呼吸衰竭接受机械通气的患者,COVID-19与非COVID-19在6个月时的新发残疾无差异。
研究设计与样本
- 研究纳入两项前瞻性观察性研究中的危重症患者,COVID-19组120例(2020年3月6日至2021年4月21日),非COVID-19组199例(2017年8月至2019年1月)。
- 纳入标准为成人(年龄≥8岁)且接受机械通气≥24小时,COVID-19患者还需SARS-CoV-2 PCR检测阳性。
主要发现
- COVID-19组年龄中位数62岁(IQR 55-71),非COVID-19组58岁(IQR 44-69),P=0.019。
- COVID-19组APACHE II评分中位数17(IQR 13-20),非COVID-19组19(IQR 15-23),P=0.011。
- COVID-19组通气时间中位数12天(IQR 5-19),非COVID-19组4.8天(IQR 2.3-8.8),P<0.001。
- 180天死亡率:COVID-19组32.5%(39/120),非COVID-19组35.2%(70/199),P=0.715。
临床怎么用
- 对于COVID-19机械通气幸存者,6个月功能结局预期与非COVID-19危重症幸存者相似,可参照后者进行康复管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: The outcomes of survivors of critical illness due to coronavirus disease (COVID-19) compared with non-COVID-19 are yet to be established. Objectives: We aimed to investigate new disability at 6 months in mechanically ventilated patients admitted to Australian ICUs with COVID-19 compared with non-COVID-19. Methods: We included critically ill patients with COVID-19 and non-COVID-19 from two prospective observational studies. Patients were eligible if they were adult (age ⩾ 8 yr) and received ⩾24 hours of mechanical ventilation. In addition, patients with COVID-19 were eligible with a positive laboratory PCR test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Measurements and Main Results: Demographic, intervention, and hospital outcome data were obtained from electronic medical records. Survivors were contacted by telephone for functional outcomes with trained outcome assessors using the World Health Organization Disability Assessment Schedule 2.0. Between March 6, 2020, and April 21, 2021, 120 critically ill patients with COVID-19, and between August 2017 and January 2019, 199 critically ill patients without COVID-19, fulfilled the inclusion criteria. Patients with COVID-19 were older (median [interquartile range], 62 [55-71] vs. 58 [44-69] yr; P = 0.019) with a lower Acute Physiology and Chronic Health Evaluation II score (17 [13-20] vs. 19 [15-23]; P = 0.011). Although duration of ventilation was longer in patients with COVID-19 than in those without COVID-19 (12 [5-19] vs. 4.8 [2.3-8.8] d; P < 0.001), 180-day mortality was similar between the groups (39/120 [32.5%] vs. 70/199 [35.2%]; P = 0.715). The incidence of death or new disability at 180 days was similar (58/93 [62.4%] vs. 99/150 [66/0%]; P = 0.583). Conclusions: At 6 months, there was no difference in new disability for patients requiring mechanical ventilation for acute respiratory failure due to COVID-19 compared with non-COVID-19. Clinical trial registered with www.clinicaltrials.gov (NCT04401254).
引用
- Hodgson CL, Higgins AM, Bailey MJ, et al. Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness. Am J Respir Crit Care Med. 2022. PMID: 35258437. doi:10.1164/rccm.202110-2335OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。